×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TVTX – travere therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TVTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/18
09:12 pm
tvtx
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
11/16
12:00 pm
tvtx
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
11/14
06:45 pm
tvtx
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
Medium
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
11/14
10:12 am
tvtx
Travere Therapeutics, Inc. (NASDAQ: TVTX) had its price target raised by analysts at Piper Sandler from $12.00 to $22.00. They now have a "neutral" rating on the stock.
Low
Report
Travere Therapeutics, Inc. (NASDAQ: TVTX) had its price target raised by analysts at Piper Sandler from $12.00 to $22.00. They now have a "neutral" rating on the stock.
11/13
05:00 pm
tvtx
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/12
06:00 pm
tvtx
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
Medium
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
11/12
04:05 pm
tvtx
Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
Low
Report
Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
11/10
11:00 am
tvtx
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
Date
Time
Symbol
Company Name
Action
%Chg
10/31/2024
07:00 am
tvtx
travere therapeutics, inc.
BEAT
Report
-2.8%
travere therapeutics, inc.
8/1/2024
04:01 pm
tvtx
travere therapeutics, inc.
BEAT
Report
-2.6%
travere therapeutics, inc.
5/6/2024
04:01 pm
tvtx
travere therapeutics, inc.
MISS
Report
3.1%
travere therapeutics, inc.
2/15/2024
04:01 pm
tvtx
travere therapeutics, inc.
BEAT
Report
-6.2%
travere therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
05:14 pm
tvtx
Form SC 13G/A Travere Therapeutics, Filed by: ARMISTICE CAPITAL, LLC
Medium
Report
Form SC 13G/A Travere Therapeutics, Filed by: ARMISTICE CAPITAL, LLC
11/14
01:01 pm
tvtx
Form SC 13G Travere Therapeutics, Filed by: Woodline Partners LP
Low
Report
Form SC 13G Travere Therapeutics, Filed by: Woodline Partners LP
11/14
09:47 am
tvtx
Form SC 13G/A Travere Therapeutics, Filed by: Deep Track Capital, LP
Low
Report
Form SC 13G/A Travere Therapeutics, Filed by: Deep Track Capital, LP
11/12
05:56 pm
tvtx
Form SC 13G/A Travere Therapeutics, Filed by: VANGUARD GROUP INC
Medium
Report
Form SC 13G/A Travere Therapeutics, Filed by: VANGUARD GROUP INC
11/8
04:56 pm
tvtx
Form SC 13G/A Travere Therapeutics, Filed by: MORGAN STANLEY
Low
Report
Form SC 13G/A Travere Therapeutics, Filed by: MORGAN STANLEY
11/8
04:15 pm
tvtx
Form 8-K Travere Therapeutics, For: Nov 07
Medium
Report
Form 8-K Travere Therapeutics, For: Nov 07
11/8
04:14 pm
tvtx
Form 424B5 Travere Therapeutics,
Medium
Report
Form 424B5 Travere Therapeutics,
11/7
04:01 pm
tvtx
Form 424B5 Travere Therapeutics,
High
Report
Form 424B5 Travere Therapeutics,
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: